Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects

Lynne M. Mofenson, Anton L. Pozniak, Jacque Wambui, Elliot Raizes, Andrea Ciaranello, Polly Clayden, Peter Ehrenkranz, Ade Fakoya, Andrew Hill, Saye Khoo, Imelda Mahaka, Surbhi Modi, Cynthia Moore, Andrew Phillips, George Siberry, Kenly Sikwese, Claire Thorne, Heather D. Watts, Meg Doherty, Nathan P. Ford